This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Thomas A. Peterman, MD, MSc; James W. Curran, MD, MPH

JAMA. 1986;256(16):2222-2226.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

AN ESTIMATED 16 000 people in the United States will develop acquired immunodeficiency syndrome (AIDS) in 1986.¹ Already, an estimated 0.5 to 1.7 million people in the United States have been infected with the human immunodeficiency virus (HIV) (also known as the human T-cell lymphotropic virus type III [HTLV-III] and the lymphadenopathy-associated virus [LAV]).^1-3 Blood donor deferral, HIV-antibody screening, and heat treatment of factor concentrates will largely prevent further transmission of HIV to recipients of these products, but blood recipients represent only 2% to 3% of all AIDS cases.¹ Sexual contact has been the route of transmission of the virus in over 78% of all AIDS cases. Moreover, the prevalence of infection with HIV is already almost 70% in at least one group of sexually active gay men.⁴ In the absence of a vaccine or therapy, the major hope for preventing transmission is the adoption of . . . [Full Text PDF of this Article]

Author Affiliations
From the AIDS Program, Center for Infectious Diseases, Centers for Disease Control, Atlanta.

Footnotes
The views expressed herein do not necessarily represent the official policies of the Centers for Disease Control or the Public Health Service.

Reprint requests to the AIDS Program, Center for Infectious Diseases, Centers for Disease Control, 1600 Clifton Rd NE, Atlanta, GA 30333 (Dr Peterman).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?